<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase I:  MAUI Imaging 2D Probe for COVID-19</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>08/01/2020</AwardEffectiveDate>
<AwardExpirationDate>07/31/2021</AwardExpirationDate>
<AwardTotalIntnAmount>254872.00</AwardTotalIntnAmount>
<AwardAmount>254872</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Henry Ahn</SignBlockName>
<PO_EMAI>hahn@nsf.gov</PO_EMAI>
<PO_PHON>7032927069</PO_PHON>
</ProgramOfficer>
<AbstractNarration>The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is an new way of imaging the entire chest and lungs, a critical capability in assisting physicians treat COVID-19 patients. Identification of COVID-19 patients with lung conditions enables accurate triage to appropriate care levels. Current imaging modalities are limited:  CT scans are limited by logistics of patient flow, re-sterilization after use, cost, and radiation risk; and conventional ultrasound cannot penetrate the full depth of lung tissue.  The proposed project will develop a portable ultrasound system for bedside low-cost, non-invasive, highly accurate imaging of the lung, delivered via remote streaming and control, for the complex logistics of COVID-19 patient care.&lt;br/&gt;&lt;br/&gt;This Small Business Innovation Research (SBIR) Phase I project will develop a portable ultrasound system for bedside non-invasive, highly accurate imaging of the lung parenchyma, mediastinum, and pleura. This project will develop core transducer components for integration into ultrasound probes, creating a 2-D imaging probe using 1-D transducer arrays. These 2-D arrays could ultimately be extended into a 3-D probe with full tomographic capabilities. The project will demonstrate the capability for lung imaging with sufficient quality to distinguish COVID-19 related issues without the need for accurate positioning, alignment, or registration.&lt;br/&gt;&lt;br/&gt;This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.</AbstractNarration>
<MinAmdLetterDate>08/10/2020</MinAmdLetterDate>
<MaxAmdLetterDate>04/16/2021</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>2030301</AwardID>
<Investigator>
<FirstName>Sateeshchandra</FirstName>
<LastName>Bajikar</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Sateeshchandra Bajikar</PI_FULL_NAME>
<EmailAddress>sateesh.bajikar@mauiimaging.com</EmailAddress>
<PI_PHON>4084640956</PI_PHON>
<NSF_ID>000778573</NSF_ID>
<StartDate>09/23/2020</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>David</FirstName>
<LastName>Specht</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>David Specht</PI_FULL_NAME>
<EmailAddress>david.specht@mauiimaging.com</EmailAddress>
<PI_PHON>4083143959</PI_PHON>
<NSF_ID>000824800</NSF_ID>
<StartDate>08/10/2020</StartDate>
<EndDate>09/23/2020</EndDate>
<RoleCode>Former Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>MAUI IMAGING, INC.</Name>
<CityName>SAN JOSE</CityName>
<CountyName/>
<ZipCode>951191212</ZipCode>
<PhoneNumber>4087441127</PhoneNumber>
<StreetAddress>70 LAS COLINAS LN</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<StateCode>CA</StateCode>
<CONGRESSDISTRICT>19</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>CA19</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>805829855</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>MAUI IMAGING, INC.</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[MAUI IMAGING, INC.]]></Name>
<CityName/>
<CountyName/>
<StateCode>CA</StateCode>
<ZipCode>951191212</ZipCode>
<StreetAddress/>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>19</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>CA19</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>5371</Code>
<Text>SBIR Phase I</Text>
</ProgramElement>
<ProgramReference>
<Code>004E</Code>
<Text>BIOMEDICAL ENG AND DIAGNOSTICS</Text>
</ProgramReference>
<ProgramReference>
<Code>096Z</Code>
<Text>COVID-19 Research</Text>
</ProgramReference>
<ProgramReference>
<Code>8038</Code>
<Text>Biotechnology</Text>
</ProgramReference>
<Appropriation>
<Code>0120</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2020~254872</FUND_OBLG>
</Award>
</rootTag>
